MétaCan
Menu
Back to cohort
Record W2758961768 · doi:10.1093/ofid/ofx163.1161

Efficacy and Effectiveness of High-Dose Influenza Vaccine for Older Adults: A Systematic Review and Meta-Analysis

2017· review· en· W2758961768 on OpenAlexaff
Jason K. H. Lee, Gary Lam, Thomas Shin, Jiyeon Kim, Anish Krishnan, Bruce T. Seet, Dion Neame, David P. Greenberg, Ayman Chit

Bibliographic record

VenueOpen Forum Infectious Diseases · 2017
Typereview
Languageen
FieldMedicine
TopicInfluenza Virus Research Studies
Canadian institutionsSanofi (Canada)York UniversityUniversity of Toronto
Fundersnot available
KeywordsMedicineMeta-analysisPathogenic organismInfluenza vaccineVirologyGerontologyIntensive care medicineInternal medicineVaccinationMicrobiology

Abstract

fetched live from OpenAlex

Seasonal influenza epidemics are responsible for significant disease burden each year, especially in adults over the age of 65. Only recently have there been vaccines that are formulated specifically for individuals 65 years of age or older, one of which, Fluzone®High-Dose (IIV3-HD), has received widespread use in the US. This study aims to review the evidence of efficacy and effectiveness of IIV3-HD compared with standard dose influenza vaccine (IIV3) in individuals aged 65 years or older against clinical outcomes plausibly related to influenza. A systematic review of four electronic databases and other sources was conducted for randomized and observational studies assessing vaccine efficacy or effectiveness (VE) of IIV3-HD against clinical outcomes such as influenza-like illness, hospital admissions and death in adults 65 years of age or older. A meta-analysis was conducted by separately extracting individual VEs reported in the studies and estimating random-effects pooled efficacy against each of the clinical outcomes. 7 eligible studies (4 randomized trials and 3 observational studies) were identified following the screening of 1,816 studies. All of these studies reported relative VE (rVE) of IIV3-HD vs. IIV3, and not absolute efficacy/effectiveness of IIV3-HD. Of those, 5 studies reported rVE for IIV3-HD vs. IIV3 against influenza-like illness, 6 studies reported rVE against hospital admissions, and 3 studies reported rVE against death. IIV3-HD demonstrated improved protection against influenza-like illness (rVE=18.3%, 95% CI: 7.0 to 28.3%), and was also more effective at preventing hospital admissions due to influenza illness (rVE=19.4%, 95% CI: 6.7 to 30.4%), pneumonia (rVE=22.4%, 95% CI: 5.0 to 36.5%), cardiorespiratory events (rVE=12.0%, 95% CI: 4.9 to 18.6%), and death following a hospital admission for influenza (rVE=22.2%, 95% CI: -18.2 to 48.8%). IIV3 also had a modest but not statistically significant impact on all-cause hospital admissions (rVE= 7.3%, 95% CI: -1.5 to 15.4%) and all-cause death (rVE=0.8%, 95% CI: -4.2 to 5.5%). There is significant evidence demonstrating IIV3-HD is more effective than standard dose influenza vaccine at reducing the clinical outcomes typically associated with influenza infection in older adults. This study was funded by sanofi pasteur. J. Lee, sanofi pasteur: Employee, Salary; G. Lam, sanofi pasteur: Employee, Salary; T. Shin, sanofi pasteur: Employee, Salary; J. Kim, sanofi pasteur: Co-op Student, Educational support; A. Krishnan, sanofi pasteur: Co-op Student, Educational support; B. Seet, sanofi pasteur: Employee and Shareholder, Salary; D. Neame, sanofi pasteur: Employee and Shareholder, Salary; D. P. Greenberg, sanofi pasteur: Employee and Shareholder, Salary; A. Chit, sanofi pasteur: Employee, Salary

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.006
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Meta-epidemiology (broad)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.576
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.006
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0190.003
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.132
GPT teacher head0.467
Teacher spread0.335 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueOpen Forum Infectious DiseasesSame topicInfluenza Virus Research StudiesFrench-language works237,207